Equity Compensation Guide for 2026: RSUs, Options, Vesting, and What Your Grant Is Actually Worth

RSUs vs stock options

The two main categories of tech-company equity grant in 2026:

• RSUs (Restricted Stock Units). A contractual promise from the company to deliver shares (or, less commonly, the cash equivalent) on a vesting schedule. The recipient does not pay anything to receive the shares; the shares are settled into the brokerage account when the vesting condition is met and the units are delivered. Tax treatment: ordinary income on the date of settlement (typically the vest date for ordinary public-company RSUs, but the timing can shift for private-company double-trigger RSUs that require an additional liquidity event), equal to the fair-market value of the delivered shares. Public companies in 2026 typically grant RSUs as the primary equity instrument.
• Stock options. The right to buy shares at a fixed exercise price (also called the strike price) for a window of time. Two main subtypes for US employees: ISOs (Incentive Stock Options) which are available only to employees of US companies and have potentially favorable long-term capital gains treatment if specific holding-period requirements are met; and NSOs (Non-qualified Stock Options) which are available more broadly and have ordinary-income tax treatment on the spread between exercise price and fair-market-value at exercise.
• Restricted stock awards (RSAs). Less common than RSUs or options; sometimes used at very early-stage companies. The recipient receives actual shares (subject to vesting) rather than a promise of shares. The 83(b) election can apply to restricted stock generally, including shares acquired by early-exercising options when those shares are subject to repurchase; it does not apply to RSUs or to an option grant itself.
• Performance Stock Units (PSUs). RSUs that vest based on company-performance metrics in addition to time, common in senior-leadership compensation packages at large public companies. The vesting can be accelerated, delayed, or canceled depending on whether the performance targets are met.

The grant type usually correlates with company stage. A pre-IPO startup typically grants ISOs to early employees; a post-IPO public company typically grants RSUs; a late-stage private company in the year before IPO often grants double-trigger RSUs that vest only on both an IPO and a normal vesting schedule. The mechanics differ in ways that matter for your tax treatment and for your exit-stage decisions.

Vesting schedules in 2026

The four-year vesting schedule with a one-year cliff remains the most common pattern at US tech companies in 2026, though variations have proliferated. The basic mechanics:

• One-year cliff. Nothing vests until the one-year anniversary of your start date (or grant date, depending on the grant agreement). On the cliff date, 25% of the grant vests as a single tranche. Before the cliff, leaving the company means forfeiting all of the grant.
• Post-cliff vesting frequency. The remaining 75% vests on a schedule across the next three years. Public companies often vest quarterly; private companies often vest monthly. Some companies vest annually after the cliff; this is less common but used by some structured-hiring companies.
• Total vesting period. Most grants vest fully over four years. Some senior-leadership grants vest over five years or longer; some highly senior grants are structured as performance-vested rather than time-vested.
• Back-loaded schedules. Some companies have moved to schedules that vest smaller percentages in early years and larger percentages in later years (5/15/40/40 across the four years, for example). The motivation is retention; the candidate-side effect is that early-departure forfeits more of the grant than a flat schedule would.
• Annual refresh grants vs multi-year front-loading. Some companies grant a single multi-year package at hire and rely on refresh grants to extend; others grant smaller annual packages each year (often after the first review cycle). Both shapes can produce similar total compensation; the second shape concentrates negotiation power at review time.

Read the specific grant agreement at offer time. Asking 'what is the vesting schedule for this grant' is a reasonable offer-stage question and the answer should be explicit; vague answers are sometimes a signal that the grant agreement has terms the recruiter would rather not foreground.

Single-trigger and double-trigger acceleration

Acceleration clauses describe what happens to the unvested portion of your grant if the company is acquired. The two main shapes:

• Single-trigger acceleration. The unvested portion vests immediately on a change of control (the acquisition closing). Single-trigger is rarer at tech companies and is typically reserved for senior leadership and founders; the rationale is that broader single-trigger creates an incentive for employees to leave shortly after acquisition, which the acquirer often does not want.
• Double-trigger acceleration. The unvested portion vests only if both the change of control happens and the employee is terminated (or sees their role materially reduced, sometimes phrased as 'terminated without cause' or 'constructively terminated') within a specified window after the acquisition. The window is typically twelve or eighteen months. Double-trigger is the more common protection at US tech companies in 2026; Cooley GO's published guidance on acceleration describes the same pattern from a startup-counsel perspective.⁶
• No acceleration. Some grants have no acceleration provision at all. In an acquisition, unvested equity transfers to the acquirer's vesting schedule, accelerates partially as a negotiated deal term, or is canceled entirely. The grant agreement and the deal terms determine the outcome.
• Modified single-trigger. Some grants accelerate a percentage of unvested equity on change of control alone (often 25% to 50%) and the rest on a double-trigger basis. The hybrid pattern protects against the employee-fired-shortly-after-acquisition scenario while retaining some retention pressure.

The honest framing for a candidate: if your grant has double-trigger acceleration, you are protected against the most common adverse-acquisition scenario (acquirer keeps your equity tied to ongoing employment but fires you shortly after closing). If your grant has no acceleration provision, you should understand that your unvested equity may simply not survive an acquisition. The acceleration terms are negotiable at senior+ levels in some companies and non-negotiable in others.

Refresh grants and the year-three problem

Without refresh grants, the equity component of your compensation effectively trends toward zero in years three and four as your initial grant vests away. By year five, you have nothing vesting; new hires at your level are receiving fresh grants while you are not. This creates the 'year-three problem' that companies address with refresh grants.

Common refresh-grant patterns:

• Annual refreshes (most common at large public companies). Each year you receive a smaller refresh grant, usually smaller than the initial grant with the exact size highly company-specific and performance-dependent, often tied to the annual performance review. The cumulative effect (over multi-year tenure) is that annual equity vesting stays roughly constant rather than trending to zero.
• Refresh on promotion. Some companies grant a larger refresh when you are promoted, in lieu of (or in addition to) an annual refresh. The promotion refresh concentrates the equity reward around growth events rather than spreading it across the calendar.
• Refresh on milestone review. Some companies have a longer review cycle (every two years for some senior roles) and refresh at that cadence. Less common but used at some structured-hiring companies.
• No refreshes. Some companies, particularly at the late-stage startup and pre-IPO stage, do not have established refresh practices. The absence of refreshes is sometimes a sign of an immature compensation function and sometimes a deliberate choice to keep employees on the original-grant trajectory.

The signal to watch at offer time: ask about the company's refresh-grant practice. The answer is informative regardless of what it is. A company that refreshes annually is often planning for long tenure; a company that does not refresh is often expecting that compensation will be addressed at promotion or by leaving and rejoining the labor market. Will Larson's StaffEng guides discuss compensation as one input to the staff+ career decision, including the refresh-grant question and how it shapes long-term comp trajectory.³

Private-company equity vs public-company equity

The valuation work is substantially harder at private companies. Public-company equity is straightforward: market price times share count, taxed as ordinary income on vest for RSUs, with subsequent capital-gains treatment if you hold the shares. Private-company equity is more uncertain across multiple dimensions:

• Valuation uncertainty. The 409A valuation (a third-party-determined fair-market-value of the common stock for tax-compliance purposes) is one input; the most recent preferred-share valuation from a funding round is another. Neither is necessarily what your equity will be worth on an exit. The actual value depends on the exit type (IPO, acquisition, or no exit), the exit price, the liquidation preferences ahead of common shares, and the dilution between now and exit.
• Liquidation preferences. Preferred shareholders (typically VCs) often have rights to receive their investment back before common shareholders (typically employees) receive anything. A 1x non-participating preference is the most common structure; participating preferences and multiple liquidation preferences are more candidate-unfriendly. Read the cap table summary if you are offered one; ask the recruiter or hiring manager if you are not.
• Dilution. Future funding rounds, employee-pool top-ups, and acquisition deal terms all dilute existing shareholders. A 0.1% ownership stake at hire often becomes a 0.05% to 0.07% stake at exit after dilution; the directional effect is clear, the magnitude is uncertain.
• Liquidity. Private-company shares are typically illiquid; you cannot sell them on an open market. Some companies have established secondary-sale programs or tender offers; others do not, in which case your equity has paper value but no realizable cash value until the company exits.

The honest expected-value framing: a $500K equity grant at a $5B-valuation Series-D startup is not worth $500K on the day you join. It is worth a probability-weighted fraction of $500K, where the probability and the fractional adjustment depend on the company stage, sector, capital structure, and exit prospects. levels.fyi's published writing treats startup-equity expected value as a recurring topic, with the consistent caveat that any specific number is an estimate informed by company-specific circumstances, not a guarantee.⁴

Tax treatment by grant type

The tax treatment of equity differs substantially by grant type and is one of the most common sources of candidate confusion. The summary below is general education; IRS Topic 427 and IRS Publication 525 are the federal-level starting points, and a CPA or tax professional should be the source of personalized analysis on consequential decisions.¹²

• RSUs. Ordinary income on the date the shares are delivered or settled (typically the vest date for ordinary public-company RSUs; private-company double-trigger RSUs that require an additional liquidity event can shift this timing). Income equals the fair-market-value of the delivered shares; the value is reported on your W-2 and federal income tax is typically withheld at delivery (often by sell-to-cover, where the company sells a portion of the delivered shares to cover the tax). If you hold the shares after delivery and they appreciate, subsequent capital-gains treatment applies on sale (short-term if held under a year, long-term if held over a year).
• Incentive Stock Options (ISOs). Available only to employees of US companies. No regular income tax at exercise (unlike NSOs), but the spread between exercise price and fair-market-value at exercise can trigger Alternative Minimum Tax (AMT). If specific holding-period requirements are met (more than two years from grant date and more than one year from exercise date), the entire gain at sale is taxed as long-term capital gains rather than ordinary income. The ISO long-term-capital-gains treatment is the most candidate-favorable equity treatment when the requirements are met; it is also the most procedurally complex, and many candidates inadvertently disqualify the favorable treatment.
• Non-qualified Stock Options (NSOs). Ordinary income at exercise on the spread between exercise price and fair-market-value. Subsequent appreciation is capital gains (short-term or long-term based on holding period after exercise). Less favorable tax treatment than ISOs but available more broadly (non-employees, certain corporate structures, etc.).
• Early exercise + 83(b) election. Some private-company grants allow you to exercise options before they have vested ('early exercise'). Combined with an 83(b) election filed with the IRS within 30 days of the early exercise, this starts the long-term capital gains clock at the exercise date, potentially reducing future tax. The trade-off: you pay the exercise price in cash now, with no guarantee that the company will succeed.

The early-exercise-with-83(b) decision is one of the highest-stakes equity decisions a tech employee makes, and it is genuinely worth paying for professional tax and financial advice. The math depends on the current 409A valuation (which determines the spread, which determines the cash required), the company's exit prospects, your overall tax situation (which determines AMT exposure), and your risk tolerance for losing the exercise cash if the company fails. A CPA or financial advisor charging a few hundred dollars for personalized analysis is often the highest-yield spend in the entire equity decision tree.

What happens to equity when you leave

The basic rule: vested equity stays with you, unvested equity is forfeited. The complications:

• Post-termination exercise window for options. Vested but unexercised options must typically be exercised within a window after termination (often 90 days, sometimes longer at candidate-friendly companies that have extended this to five or ten years). After the window expires, vested options are lost. If exercising requires substantial cash and you cannot afford it, the options effectively expire even though they were vested. ISO-specific caveat: ISOs exercised more than three months after termination generally lose their ISO tax treatment and are taxed as NSOs at exercise; this trade-off is part of why extended-window programs are sometimes contentious despite being broadly candidate-friendly. The extended-window practice (introduced by some companies in the 2010s) is meaningfully candidate-friendly and is a fair offer-time question.
• Vested RSU shares are yours. Vested shares delivered to your brokerage account are unconditionally yours; leaving the company does not affect them. The unvested portion of the RSU grant is forfeited at termination.
• Severance acceleration. Some severance agreements include partial equity acceleration as a negotiated term (typically a few months of additional vesting, sometimes more for senior roles). Severance acceleration is non-standard but more common at senior+ levels and worth asking about when negotiating a severance.
• Termination for cause vs without cause. Some grant agreements treat termination for cause differently from termination without cause, sometimes including clawback provisions for vested equity. Read the grant agreement carefully if your departure is contentious.
• The 90-day exercise window after a layoff. If you are laid off and have private-company options, the post-termination exercise window starts running. Decide quickly whether you can afford to exercise; once the window closes, vested options are lost.

Questions to ask at offer time

The offer is the best moment to learn the equity terms that decide your next four years of compensation. Most candidates ask about base salary and grant size; the candidates who do better often ask about the structural terms below.

1. What is the vesting schedule? Specifically: cliff length, post-cliff frequency, and any back-loading. The grant agreement is the source of truth.
2. What is the acceleration provision? Single-trigger, double-trigger, no acceleration, or modified single-trigger. If double-trigger, what is the window after change of control during which termination triggers acceleration?
3. What is the company's refresh-grant practice? Annual refreshes? On-promotion refreshes? Milestone refreshes? No refreshes? The answer often signals long-term retention strategy.
4. What is the post-termination exercise window for options? 90 days is standard; five or ten years is candidate-friendly. The difference matters enormously for private-company options.
5. What is the most recent 409A valuation, and when was the last funding round? Helps you estimate current grant value, although the actual exit value depends on many factors beyond the current valuation.
6. Does the company offer a secondary-sale program or tender offer? For pre-IPO private companies, the answer determines whether you have realistic liquidity options before exit.
7. What is the company's ISO/NSO classification for new hires? ISOs have more favorable potential tax treatment; NSOs are more flexible but less favorable. The classification often depends on company structure rather than candidate negotiation, but it is worth knowing.